565 related articles for article (PubMed ID: 16767079)
1. Myc-binding-site recognition in the human genome is determined by chromatin context.
Guccione E; Martinato F; Finocchiaro G; Luzi L; Tizzoni L; Dall' Olio V; Zardo G; Nervi C; Bernard L; Amati B
Nat Cell Biol; 2006 Jul; 8(7):764-70. PubMed ID: 16767079
[TBL] [Abstract][Full Text] [Related]
2. Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification.
Hiroi H; Christenson LK; Strauss JF
Mol Cell Endocrinol; 2004 Feb; 215(1-2):119-26. PubMed ID: 15026184
[TBL] [Abstract][Full Text] [Related]
3. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin.
Vakoc CR; Mandat SA; Olenchock BA; Blobel GA
Mol Cell; 2005 Aug; 19(3):381-91. PubMed ID: 16061184
[TBL] [Abstract][Full Text] [Related]
4. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.
Frank SR; Schroeder M; Fernandez P; Taubert S; Amati B
Genes Dev; 2001 Aug; 15(16):2069-82. PubMed ID: 11511539
[TBL] [Abstract][Full Text] [Related]
5. Genomic binding and transcriptional regulation by the Drosophila Myc and Mnt transcription factors.
Orian A; Grewal SS; Knoepfler PS; Edgar BA; Parkhurst SM; Eisenman RN
Cold Spring Harb Symp Quant Biol; 2005; 70():299-307. PubMed ID: 16869766
[TBL] [Abstract][Full Text] [Related]
6. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
7. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells.
Dahl JA; Collas P
Stem Cells; 2007 Apr; 25(4):1037-46. PubMed ID: 17272500
[TBL] [Abstract][Full Text] [Related]
8. Integrating genomic data to predict transcription factor binding.
Holloway DT; Kon M; DeLisi C
Genome Inform; 2005; 16(1):83-94. PubMed ID: 16362910
[TBL] [Abstract][Full Text] [Related]
9. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
Zhang Y; Sif S; DeWille J
J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
[TBL] [Abstract][Full Text] [Related]
10. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
[TBL] [Abstract][Full Text] [Related]
11. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation.
Im H; Grass JA; Johnson KD; Boyer ME; Wu J; Bresnick EH
Methods Mol Biol; 2004; 284():129-46. PubMed ID: 15173613
[TBL] [Abstract][Full Text] [Related]
12. LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription.
Amente S; Bertoni A; Morano A; Lania L; Avvedimento EV; Majello B
Oncogene; 2010 Jun; 29(25):3691-702. PubMed ID: 20418916
[TBL] [Abstract][Full Text] [Related]
13. ChromaSig: a probabilistic approach to finding common chromatin signatures in the human genome.
Hon G; Ren B; Wang W
PLoS Comput Biol; 2008 Oct; 4(10):e1000201. PubMed ID: 18927605
[TBL] [Abstract][Full Text] [Related]
14. Tilling the chromatin landscape: emerging methods for the discovery and profiling of protein-DNA interactions.
Rodriguez BA; Huang TH
Biochem Cell Biol; 2005 Aug; 83(4):525-34. PubMed ID: 16094456
[TBL] [Abstract][Full Text] [Related]
15. Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays.
Rada-Iglesias A; Wallerman O; Koch C; Ameur A; Enroth S; Clelland G; Wester K; Wilcox S; Dovey OM; Ellis PD; Wraight VL; James K; Andrews R; Langford C; Dhami P; Carter N; Vetrie D; Pontén F; Komorowski J; Dunham I; Wadelius C
Hum Mol Genet; 2005 Nov; 14(22):3435-47. PubMed ID: 16221759
[TBL] [Abstract][Full Text] [Related]
16. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking.
Lee BM; Mahadevan LC
J Cell Biochem; 2009 Sep; 108(1):22-34. PubMed ID: 19623574
[TBL] [Abstract][Full Text] [Related]
17. The genomic landscape of histone modifications in human T cells.
Roh TY; Cuddapah S; Cui K; Zhao K
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15782-7. PubMed ID: 17043231
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide epigenetic analysis of human pluripotent stem cells by ChIP and ChIP-Seq.
Hitchler MJ; Rice JC
Methods Mol Biol; 2011; 767():253-67. PubMed ID: 21822881
[TBL] [Abstract][Full Text] [Related]
19. Progress and challenges in profiling the dynamics of chromatin and transcription factor binding with DNA microarrays.
Hanlon SE; Lieb JD
Curr Opin Genet Dev; 2004 Dec; 14(6):697-705. PubMed ID: 15531167
[TBL] [Abstract][Full Text] [Related]
20. An integrated map of p53-binding sites and histone modification in the human ENCODE regions.
Kaneshiro K; Tsutsumi S; Tsuji S; Shirahige K; Aburatani H
Genomics; 2007 Feb; 89(2):178-88. PubMed ID: 17085012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
